20
Nov
2020
As eff orts continue to fi nd an eff ective treatment and vaccine for covid-19, monoclonal antibodies have been at the forefront of research with reportedly more than 100 covid-19 antibody treatments at various stages of clinical trials – some designed solely to deal with secondary eff ects of SARS-CoV-2 (eg, infl ammation), while others are designed to destroy the virus itself. Read more